Small Pharma Inc.
Small Pharma Inc. (DMTTF) Revenue
Annual & quarterly revenue history · segment & region breakdown
DMTTF · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsSmall Pharma Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Small Pharma Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Small Pharma Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Small Pharma Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
DMTTF revenue · 4 questionsDMTTF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Small Pharma Inc. SEC filings · GAAP · Small Pharma Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026